NSC |
Compound |
Enrichment |
Correlation |
NSC 693322 |
Hydrazinecarbothioamide, 2,2'-(1,2-ethanediylidene)bis[N,N-dimethyl- |
0.0348993771550531 |
0.095356923 |
NSC 700862 |
4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- |
0.0348993771550531 |
0.07731077 |
NSC 703784 |
L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride |
0.0348993771550531 |
-0.0048131002 |
NSC 717468 |
Null |
0.0348993771550531 |
0.03366761 |
NSC 718564 |
Null |
0.0348993771550531 |
0.0066083045 |
NSC 726089 |
11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate |
0.0348993771550531 |
0.040709702 |
NSC 726217 |
Combretastatin A4-analogue |
0.0348993771550531 |
0.22450617 |
NSC 728078 |
2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide |
0.0348993771550531 |
0.12837422 |
NSC 731701 |
1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate |
0.0348993771550531 |
-0.079170886 |
NSC 731704 |
1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. |
0.0348993771550531 |
0.10169645 |